Logo image
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
Journal article   Open access   Peer reviewed

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

William E. Klunk, Julie C. Price, Chester A. Mathis, Nicholas D. Tsopelas, Brian J. Lopresti, Scott K. Ziolko, Wenzhu Bi, Jessica A. Hoge, Ann D. Cohen, Milos D. Ikonomovic, …
The Journal of neuroscience, v 27(23), pp 6174-6184
06 Jun 2007
PMID: 17553989
url
https://doi.org/10.1523/jneurosci.0730-07.2007View
Published, Version of Record (VoR)CC BY V4.0 Open
url
https://doi.org/10.1523/JNEUROSCI.0730-07.2007View
Published, Version of Record (VoR) Open

Abstract

Alzheimer's disease amyloid-β diagnosis Pittsburgh Compound-B positron emission tomography striatum
The amyloid cascade hypothesis suggests that the aggregation and deposition of amyloid-β protein is an initiating event in Alzheimer's disease (AD). Using amyloid imaging technology, such as the positron emission tomography (PET) agent Pittsburgh compound-B (PiB), it is possible to explore the natural history of preclinical amyloid deposition in people at high risk for AD. With this goal in mind, asymptomatic ( n = 5) and symptomatic ( n = 5) carriers of presenilin-1 (PS1) mutations (C410Y or A426P) that lead to early-onset AD and noncarrier controls from both kindreds ( n = 2) were studied with PiB–PET imaging and compared with sporadic AD subjects ( n = 12) and controls from the general population ( n = 18). We found intense and focal PiB retention in the striatum of all 10 PS1 mutation carriers studied (ages 35–49 years). In most PS1 mutation carriers, there also were increases in PiB retention compared with controls in cortical brain areas, but these increases were not as great as those observed in sporadic AD subjects. The two PS1 mutation carriers with a clinical diagnosis of early-onset AD did not show the typical regional pattern of PiB retention observed in sporadic AD. Postmortem evaluation of tissue from two parents of PS1C410Y subjects in this study confirmed extensive striatal amyloid deposition, along with typical cortical deposition. The early, focal striatal amyloid deposition observed in these PS1 mutation carriers is often is not associated with clinical symptoms.

Metrics

10 Record Views
356 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Neurosciences
Logo image